Cargando...

Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers

Trastuzumab, an epidermal growth factor receptor 2 (HER2) targeting humanized monoclonal antibody, has been approved for the treatment HER2-positive breast cancer and HER2-positve metastatic gastric cancer. However, cardiotoxicity associated with its clinical application poses challenges for clinici...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antib Ther
Autores principales: Mohan, Nishant, Jiang, Jiangsong, Dokmanovic, Milos, Wu, Wen Jin
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6131716/
https://ncbi.nlm.nih.gov/pubmed/30215054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/abt/tby003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!